Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.49 |
| ▸ | MEN1 | O00255 | 4/20 | 0.49 |
| ▸ | HTT | P42858 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 4/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | CASP3 | P42574 | 1/20 | 0.42 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.42 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22215853 | 0.85 | ALDH1A1 (0.46) | KMT2AMEN1HTTALDH1A1NPSR1 | |
| SCHEMBL12370700 | 0.84 | KMT2A (0.44) | KMT2AMEN1HTTALDH1A1NPSR1 | |
| SCHEMBL28268634 | 0.83 | ALOX15 (0.54) | KMT2AMEN1HTTALDH1A1NPSR1 | |
| SCHEMBL9638081 | 0.82 | MEN1 (0.43) | KMT2AMEN1HTTALDH1A1NPSR1 | |
| SCHEMBL2850836 | 0.81 | SMN1; SMN2 (0.43) | KMT2AMEN1HTTALDH1A1NPSR1 | |
| SCHEMBL9491208 | 0.81 | ALDH1A1 (0.47) | KMT2AMEN1HTTALDH1A1NPSR1 | |
| SCHEMBL9186644 | 0.80 | MEN1 (0.43) | KMT2AMEN1HTTALDH1A1NPSR1 | |
| SCHEMBL3920762 | 0.80 | MAPT (0.54) | KMT2AMEN1HTTALDH1A1NPSR1 | |
| SCHEMBL30883282 | 0.80 | ALDH1A1 (0.52) | KMT2AMEN1HTTALDH1A1NPSR1 | |
| SCHEMBL13259832 | 0.79 | MEN1 (0.48) | KMT2AMEN1HTTALDH1A1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100204038-A1 | Catalysts based on metal complexes for the synthesis of optically active chrysanthemic acid | CARLONI SILVIA | 2010-08-12 | — | — | US | disclosed |
| EP-1765496-B1 | CATALYSTS BASED ON COPPER COMPLEXES FOR THE SYNTHESIS OF OPTICALLY ACTIVE CHRYSANTHEMIC ACID | ENDURA SPA (IT) | 2010-07-14 | — | — | EP | disclosed |
| US-7723539-B2 | Catalysts based on metal complexes for the synthesis of optically active chrysanthemic acid | ENDURA S.P.A. (IT) | 2010-05-25 | — | — | US | disclosed |
| US-20080021237-A1 | Catalysts Based on Metal Complexes for the Synthesis of Optically Active Chrysanthemic Acid | ENDURA S.P.A. (IT) | 2008-01-24 | — | — | US | disclosed |
| EP-1765496-A1 | CATALYSTS BASED ON METAL COMPLEXES FOR THE SYNTHESIS OF OPTICALLY ACTIVE CHRYSANTHEMIC ACID | ENDURA S.p.A. (IT) | 2007-03-28 | — | — | EP | disclosed |
| WO-2005123254-A1 | CATALYSTS BASED ON METAL COMPLEXES FOR THE SYNTHESIS OF OPTICALLY ACTIVE CHRYSANTHEMIC ACID | ENDURA S.P.A. (IT) | 2005-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080021237-A1 | Catalysts Based on Metal Complexes for the Synthesis of Optically Active Chrysanthemic Acid | SCO2, ME1, ME3 | KMT2A 3134/4885MEN1 786/4885HTT 2685/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.